SRx Health Solutions Inc

SRXH

Latest QuantConomy context for SRXH: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NYSE MKT

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for SRXH. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for SRXH

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
corporate event reg fd disclosure	neutral	70	Jul 10, 08:55 PM	SRXH filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal]
fundamental eps change	very bullish	76	May 14, 12:00 AM	SRXH (Q2 2026, diluted eps): EPS grew 92.3% ($-0.26 → $-0.02). [sequential period basis, very bullish signal]
corporate event reg fd disclosure	neutral	70	Jun 26, 07:00 PM	SRXH filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
SRXH	NYSE MKT	alphavantage	Better Choice Company Inc
SRXH	NYSE	fmp	SRx Health Solutions Inc.

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Dec 3, 2025	Conway Simon Alexander Malcolm	Insider	grant	630,000	$0.39	$245,700	4 on EDGAR
Dec 3, 2025	Cunningham Kent Douglas	Chief Executive Officer	grant	200,000	$0.39	$78,000	4 on EDGAR
—	Cunningham Kent Douglas	Chief Executive Officer	—	—	—	—	3 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.